- Travel Insurance
- Why Insurancewith?
- Help Centre
- Travel Tips & Advice
- Other Insurances
Nick Talbot is a cystic fibrosis sufferer on a mission. Climbing Everest is the type of challenge that most able-bodied people might find horrifically imposing, but for someone whose lungs and other organs are under attack on a daily basis from their own body, the motivation behind wanting to climb Everest is inspiring.
Should Nick succeed, he will be the first man with cystic fibrosis to climb to the summit of Everest, the world’s highest mountain.
Nick announced his plans in November of 2013, and was met with great support from cystic fibrosis sufferers around the country and the charity he is hoping to face £100,000 for – the Cystic Fibrosis Trust.
On the challenge Nick said: “I’ve had a few ups and downs but my health has generally been much better than most people who have cystic fibrosis. I’m also lucky to benefit from a new medication which can only help a small percentage of people with CF and has meant that my lung function has improved and my health is even more stable. This has allowed me to attempt such a huge feat. It will be really tough, but I know some with cystic fibrosis have to endure fighting to walk and breathe every day. I’m doing this for them.”
Unfortunately, Nick’s planned attempt was cancelled last week as an avalanche on April 18th caused one Sherpa guide to be killed and five more to be seriously injured. Nick and his team have had to have been evacuated from the mountain as reports say the avalanche was the worst disaster in the mountain’s history.
Vicky Bratherton, Regional Fundraising Manager for Greater London at the Cystic Fibrosis Trust, said: “We would like to send our condolences to everyone affected by the tragic events last week, especially the families of those who lost their lives.
“Nick has received a huge amount of support from across the cystic fibrosis community and beyond, throughout his expedition. We will share any plans for the future as they emerge after Nick returns to the UK.”